Search
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
Invitrogen
Methyl Mercury Chloride Recombinant Mouse Monoclonal Antibody (2F8)
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Methyl Mercury Chloride Antibody (MA566418) in SDS-PAGE
SDS-PAGE characterization of Methyl Mercury Chloride under reducing conditions. Lane M: Protein marker (kDa); Lane CH3HgCl: Purified Methyl Mercury Chloride Recombinant Monoclonal (Product # MA566418). Methyl Mercury Chloride showing heavy chain (~50 kDa) and light chain (~25 kDa). Gels were stained with Coomassie Brilliant Blue R-355.
产品信息
MA566418
产品规格
种属反应
Chemical
宿主/亚型
Mouse
/ IgG
Expression System
CHO cells
分类
Recombinant Monoclonal
类型
Antibody
克隆号
2F8
抗原
Conjugate of CH3HgCl hapten and KLH.
偶联物
形式
Liquid
浓度
4.2 mg/mL
纯化类型
Protein G
保存液
PBS
内含物
0.09% sodium azide
保存条件
-20°C
运输条件
Ambient (domestic); Wet ice (international)
靶标信息
Methyl Mercury Chloride is a biosimilar compound that has been studied for its structural and functional similarities to its originator molecules. The biosimilar development process involves rigorous analytical methods to ensure that the structure, including post-translational modifications, and functionality are comparable to the original product. This compound is often analyzed using techniques such as hydrophilic interaction chromatography and mass spectrometry to assess its molecular size and complex protein structure. The clinical considerations for biosimilar antibodies like Methyl Mercury Chloride include understanding their potential impact on clinical outcomes, given their large molecular size and complex protein structure. The development and approval processes for biosimilars depend heavily on their comparability to originators, minimizing the risk of clinically meaningful differences.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
篇参考文献 (0)
您是否在文献中引用过该产品？请点击下方按钮邮件告知我们。
